Among these, NSCLC mutated in Liver kinase B1 (LKB1/STK11) gene represent one-third of the cases and LKB1/STK11 is considered the third most commonly mutated gene in NSCLC adenocarcinomas, after TP53 and KRAS (4). This evidence concerns the gene KRAS and non-small cell lung carcinoma.